There is amplification of FGFR1 and FGFR2 in ER+ breast cancer and TNBC, respectively, and FGFR1 amplification was noted as an independent factor to predict the overall survival in ER + breast cancer (7). The gene discussed is FGFR2; the disease is breast carcinoma.